Annette Neylon

1.1k total citations
7 papers, 329 citations indexed

About

Annette Neylon is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Annette Neylon has authored 7 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 4 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Annette Neylon's work include Multiple Myeloma Research and Treatments (4 papers), Cancer Treatment and Pharmacology (3 papers) and Blood donation and transfusion practices (1 paper). Annette Neylon is often cited by papers focused on Multiple Myeloma Research and Treatments (4 papers), Cancer Treatment and Pharmacology (3 papers) and Blood donation and transfusion practices (1 paper). Annette Neylon collaborates with scholars based in New Zealand, United States and Greece. Annette Neylon's co-authors include Penelope R. A. Taylor, Martin Howard, Stephen J. Proctor, P. W. G. Saunders, David Marín, Sarah Marktel, M Bua, Anne Lennard, Richard Szydlo and Thanyaphong Na Nakorn and has published in prestigious journals such as British Journal of Haematology, Leukemia and Reproductive BioMedicine Online.

In The Last Decade

Annette Neylon

7 papers receiving 320 citations

Peers

Annette Neylon

HEMAT

GENET

PFM

RHEUM

PRM

Maria Teresa Scimò Italy

Jaime Garcı́a-Chávez Mexico

P. W. G. Saunders United Kingdom

Mariano Linares Spain

Morie A. Gertz United States

Vlatko Pejša Croatia

L. Robert Hanrahan United States

Nadia Dallera Italy

Patrizia Melis Italy

Margaret Michalska United States

Maria Teresa Scimò Italy

Annette Neylon

308 ×1.0

HEMAT

62 ×0.7

GENET

78 ×1.2

PFM

20 ×0.5

RHEUM

23 ×0.6

PRM

Citations per year, relative to Annette Neylon Annette Neylon (= 1×) peers Maria Teresa Scimò

Countries citing papers authored by Annette Neylon

Since Specialization

Citations

This map shows the geographic impact of Annette Neylon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annette Neylon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annette Neylon more than expected).

Fields of papers citing papers by Annette Neylon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annette Neylon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annette Neylon. The network helps show where Annette Neylon may publish in the future.

Co-authorship network of co-authors of Annette Neylon

This figure shows the co-authorship network connecting the top 25 collaborators of Annette Neylon. A scholar is included among the top collaborators of Annette Neylon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annette Neylon. Annette Neylon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Chan, Henry, et al.. (2020). Electronic FRAIL score may predict treatment outcomes in older adults with myeloma. Journal of Geriatric Oncology. 12(4). 515–520. 3 indexed citations

2.

Capra, Marcelo, Meral Beksaç, Paul G. Richardson, et al.. (2020). ISATUXIMAB PLUS POMALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND SOFT-TISSUE PLASMACYTOMAS: ICARIA-MM SUBGROUP ANALYSIS. Hematology Transfusion and Cell Therapy. 42. 263–264. 4 indexed citations

3.

Quach, Hang, Gillian Corbett, Peter Browett, et al.. (2017). Upfront lower dose lenalidomide is less toxic and does not compromise efficacy for vulnerable patients with relapsed refractory multiple myeloma: final analysis of the phase II RevLite study. British Journal of Haematology. 177(3). 441–448. 15 indexed citations

4.

Quach, Hang, Simon J. Harrison, Gillian Corbett, et al.. (2015). Lower Dose Lenalidomide-Dexamethasone is Less Toxic and does not Compromise Efficacy for Patients with Relapsed/Refractory multiple myeloma who are aged ≥60 years and/or with renal impairment and/or with thrombocytopenia. Clinical Lymphoma Myeloma & Leukemia. 15. e284–e285. 1 indexed citations

5.

Neylon, Annette, et al.. (2003). Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population‐based cohort of 245 patients. British Journal of Haematology. 122(6). 966–974. 248 indexed citations

6.

Marín, David, Sarah Marktel, M Bua, et al.. (2003). Prognostic factors for patients with chronic myeloid leukaemia in chronic phase treated with imatinib mesylate after failure of interferon alfa. Leukemia. 17(8). 1448–1453. 57 indexed citations

7.

Neylon, Annette, et al.. (2000). Severe haemophilia following use of donor eggs: implications for screening of prospective donors. Reproductive BioMedicine Online. 1(2). 34–37. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact